What ORIC Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 7 | 16 |
| Total trades | 13 | 29 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 108,500 | 321,866 |
| Disposed | 111,700 | 238,614 |
| Net activity | −3,200 | +83,252 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer | Oct 20 | Open-market sale · S | −14,000 | $13.53 | −$189K | 69,828 |
| Piscitelli Dominic | Chief Financial Officer | Oct 20 | Exercise / conversion · M | +14,000 | $4.36 | +$61K | 83,828 |
| Heyman Richard A. | Director | Oct 01 | Open-market sale · S | −3,200 | $12.91 | −$41.3K | 203,472 |
| Heyman Richard A. | Director | Oct 01 | Open-market sale · S | −3,500 | $12.91 | −$45.2K | 38,300 |
| Heyman Richard A. | Director | Oct 01 | Exercise / conversion · M | +3,500 | $1.60 | +$5.6K | 41,800 |
| Piscitelli Dominic | Chief Financial Officer | Sep 28 | Open-market sale · S | −13,400 | $13.53 | −$181K | 69,828 |
| Piscitelli Dominic | Chief Financial Officer | Sep 28 | Exercise / conversion · M | +13,400 | $4.36 | +$58.4K | 83,228 |
| Piscitelli Dominic | Chief Financial Officer | Sep 24 | Open-market sale · S | −500 | $13.51 | −$6.75K | 69,828 |
| Piscitelli Dominic | Chief Financial Officer | Sep 24 | Open-market sale · S | −100 | $13.50 | −$1.35K | 70,328 |
| Piscitelli Dominic | Chief Financial Officer | Sep 24 | Exercise / conversion · M | +600 | $4.36 | +$2.62K | 70,428 |
| Piscitelli Dominic | Chief Financial Officer | Aug 26 | Open-market sale · S | −77,000 | $13.69 | −$1.05M | 69,828 |
| Piscitelli Dominic | Chief Financial Officer | Aug 26 | Exercise / conversion · M | +25,000 | $6.00 | +$150K | 146,828 |
| Piscitelli Dominic | Chief Financial Officer | Aug 26 | Exercise / conversion · M | +52,000 | $4.36 | +$227K | 121,828 |
| Heyman Richard A. | Director | Jul 24 | Open-market sale · S | −6,100 | $12.02 | −$73.3K | 206,672 |
| Heyman Richard A. | Director | Jul 24 | Open-market sale · S | −7,000 | $12.02 | −$84.1K | 38,300 |
| Heyman Richard A. | Director | Jul 24 | Exercise / conversion · M | +3,500 | $1.60 | +$5.6K | 45,300 |
| Heyman Richard A. | Director | Jul 06 | Open-market sale · S | −300 | $12.00 | −$3.6K | 212,772 |
| Piscitelli Dominic | Chief Financial Officer | Feb 24 | Open-market sale · S | −52,000 | $13.51 | −$703K | 68,148 |
| Piscitelli Dominic | Chief Financial Officer | Feb 24 | Exercise / conversion · M | +52,000 | $4.36 | +$227K | 120,148 |
| Heyman Richard A. | Director | Jan 16 | Open-market sale · S | −3,200 | $12.00 | −$38.4K | 213,072 |
Loading...
